Standard Vascepa Dosage
Vascepa (icosapent ethyl) is approved for two main uses in adults: reducing cardiovascular risk in patients with elevated triglycerides (≥150 mg/dL) on statin therapy, and treating severe hypertriglyceridemia (≥500 mg/dL). The standard dosage is 4 grams per day, taken as 2 grams twice daily with food.[1]
Adjustments for Renal Impairment
Mild or moderate kidney problems do not require dosage changes. For severe renal impairment (e.g., creatinine clearance <30 mL/min), use caution due to limited data—no specific dosage reduction is mandated, but monitor triglycerides and adjust based on response.[1][2]
Hepatic Impairment Considerations
No dosage adjustments are needed for mild to moderate liver impairment. Vascepa has not been studied in severe hepatic impairment (Child-Pugh C), so avoid use in those patients.[1]
No Adjustments for Age, Weight, or Gender
Dosage remains 4 grams daily regardless of age (including elderly), body weight, or gender. No pediatric dosing exists, as approval is for adults only.[1]
Impact of Drug Interactions on Effective Dosage
Certain health history elements, like concurrent medications, indirectly affect dosing:
- Use with fibrates (e.g., gemfibrozil) increases Vascepa exposure; monitor for myopathy risk, but dosage stays standard.
- Avoid cyclosporine due to elevated icosapent ethyl levels; no formal dosage change, but assess risk-benefit.[1][2]
Contraindications Tied to Health History
Vascepa is contraindicated in patients with known hypersensitivity to icosapent ethyl or components. Pre-existing gallbladder issues or pancreatitis risk from hypertriglyceridemia warrant monitoring, not dosage changes.[1]
[1]: Vascepa Prescribing Information (FDA)
[2]: Drugs.com - Vascepa Dosage Guide